Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> China Pharma Providers
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Pharma Providers
Type:
CRO-Discovery
Title:
Vector Gene Technology Co Ltd
Chinese
CSertification:
n/a
International
Certification:
n/a
Primary Location:
Beijing
China
Contact Info:
n/a
Webpage:
www.agtc.com.cn
HQ
Contact Info:
No.6 Yongchang Zhong Lu, Beijing Economic and Technical Development Area (BDA) Beijing, 100176, China
Tel: +86 10 6787 1177 EXT. 145 or 168 Fax: +86 10 6787 7776
E-mail: david_y@agtc.com.cn; sales@agtc.com.cn
Additional
Contact Info:
n/a
Description:
The company (VGTC), established in Oct. 2000, is an expert in gene vector technologies, primarily engaged in the research and development of gene transfer technologies and gene therapeutics. Its original gene vector technology was created by a group of scientists focusing on viral vectors research and development in Chinese National Key Laboratory of Molecular Virology and Genetic Engineering.
The company was once located in an incubator lab in the BDA (Beijing Economic and Technical Development Area) between 2000-2002. From July of 2002 on, increased business allowed VGTC to move into its own buildings including 4,300 sq. ft. GMP facility, 8,600 sq. ft. GLP laboratory and 1,100 sq. ft. SPF animal laboratory.
VGTC is a leader in recombinant adeno-associated virus (rAAV) large-scale manufacturing. Its novel AAV package and purification systems make the producing of AAV to be one of the most cost-effective AAV producing systems.
With the advent of virally and plasmid-DNA mediated vaccine and gene therapy, VGTC used its decade of expertise in virology and cell culture to offer a GMP contract production service. With the lots of non-GMP and GMP manufacturing service of AAV, Adenovirus and Plasmid-DNA for the clients in China and abroad, VGTC is becoming one of the most important vector-manufacturing service companies in China.
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit